Company: OTSA
Filing Date: 2025-05-23
Form Type: DRS/A
Source: 0001213900-25-047247
Chunk: 157

Company: OTSAW Ltd
Filing Date: 2025-05-23
Form: DRS/A
Chunk 157
---
minsights.com/industry -analysis /robotic -software-market 98 As compared to ANS Version 1 which is compatible for single specific robot use and ANS Version 2 which is compatible for the Otsaw product range only, we envision the Odyssey to be a universal software system that will be licensed and installed to host most, if not all, third -partyAMR and robotic frameworks. With Odyssey being the software solution, the third -partyAMR and robotic manufacturer and developer only need to develop the hardware and application for their robotics products. As part of the Odyssey ANS, we plan to provide Application Programming Interface (API) support and software development kits for third -partyAMR and robotics companies to integrate the Odyssey to their robotics products and to tailor Odyssey’s applications to their unique needs and product design. Not only will the Odyssey provide an additional source of revenue by leveraging our existing software and AI technology, we believe that by commercializing software technology to other robots and AMRs manufacturers and developers, it will provide us with the means to be a prominent AI and AMR software solution provider to the entire robotic industry. We believe the world is entering a new era where robots will become increasingly prevalent in all sectors, and thus we believe the Odyssey will expand our ecosystem coverage by integrating our core software technologies with all relevant players in the robotics industry. By licensing our software technologies to the pool of players in the robotics industry, the Odyssey, as an all -in -oneANS, opens up numerous applications and tremendous monetization opportunities that go beyond our current product offering. We envision the Odyssey to become the dominant ANS that represents the future trend for autonomous robotics software technology. Expansion of Our Production Capacity for Cost-Efficient Manufacturing and Competitive Pricing We intend to expand the production capacity of our AMRs. With our organic growth, the increasing popularity of our products, the joint ventures with Swisslog Healthcare, the expansion of our distributor network and channels and other potential strategic partnerships with various industry leaders, we expect an increase in orders for our AMRs, UV -Cdisinfection systems, and other products globally and a continuous rise in sales volume in the future. Our goal is to expand our production capacity to have at least three months of finished products as the inventory to sell/lease at any given time. Expanding our production capacity enables us to meet our projected demand. This will lower manufacturing costs through economies of scale and improve overall cost -efficiencyand profit margins. Ultimately, we will be able to provide our AMR and robotics